相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer
Sarah B. Gitto et al.
GYNECOLOGIC ONCOLOGY (2020)
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
Christina Friese et al.
SCIENTIFIC REPORTS (2020)
Harnessing natural killer cells for the treatment of ovarian cancer
Janneke S. Hoogstad-van Evert et al.
GYNECOLOGIC ONCOLOGY (2020)
1 Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
Dmitriy Zamarin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature
Chao Yang et al.
ELIFE (2020)
Transcriptional Regulation of Natural Killer Cell Development and Functions
Dandan Wang et al.
CANCERS (2020)
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
Helen Kotanides et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Emerging roles of and therapeutic strategies targeting BRD4 in cancer
Mary E. White et al.
CELLULAR IMMUNOLOGY (2019)
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C. Miller et al.
NATURE IMMUNOLOGY (2019)
The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc
Han Dong et al.
NATURE IMMUNOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Ovarian Cancer Immunotherapy: Turning up the Heat
Eleonora Ghisoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost et al.
NATURE MEDICINE (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Haoyu Sun et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins et al.
CANCER DISCOVERY (2018)
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
Chaoyang Sun et al.
CANCER CELL (2018)
Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
Roisin M. Loftus et al.
NATURE COMMUNICATIONS (2018)
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J. Hill et al.
CANCER DISCOVERY (2018)
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal et al.
CELL (2018)
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
Hanghang Zhang et al.
CELL (2018)
Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics
Marlon Stoeckius et al.
GENOME BIOLOGY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
Lea Bouche et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Chromatin states define tumour-specific T cell dysfunction and reprogramming
Mary Philip et al.
NATURE (2017)
Markers and Function of Human NK Cells in Normal and Pathological Conditions
Genny Del Zotto et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner et al.
NATURE METHODS (2016)
Can advanced-stage ovarian cancer be cured?
Steven Narod
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex
Arnulf Hertweck et al.
CELL REPORTS (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Diffusion maps for high-dimensional single-cell analysis of differentiation data
Laleh Haghverdi et al.
BIOINFORMATICS (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Histone acetylation mediated by Brd1 is crucial for Cd8 gene activation during early thymocyte development
Yuta Mishima et al.
NATURE COMMUNICATIONS (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population
Curtis W. McCloskey et al.
FRONTIERS IN ONCOLOGY (2014)
Cancer-related inflammation: Common themes and therapeutic opportunities
Frances R. Balkwill et al.
SEMINARS IN CANCER BIOLOGY (2012)
The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis
Yuta Mishima et al.
BLOOD (2011)
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Hyun-Tak Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Thierry Walzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation
M Yagita et al.
LEUKEMIA (2000)
分享论文
